Comparison Chart Corbus Pharmaceuticals Holdings, Inc.
Stocks
CRBP
US21833P3010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 03/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.130 USD | -3.31% |
|
-14.15% | -24.69% |
| 09-14 | Corbus Pharmaceuticals Holdings, Inc. - Special Call | |
| 09-14 | Corbus Pharma Reports Positive Top-Line Data From Weight-Loss Drug Study | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Bio Therapeutic Drugs | -3.31% | -14.15% | -24.69% | -52.88% | -79.97% | 119M |
- Stock Market
- Stocks
- CRBP Stock
- Charts Corbus Pharmaceuticals Holdings, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















